Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Dec
17
2018
New York Tightens Its Grip on CBD Even as the Feds Ease Industrial Hemp Restrictions Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
17
2018
ISO Publishes Specification for Developing Representative Test Materials Consisting of Nano-Objects in Dry Powder Form Bergeson & Campbell, P.C.
Dec
17
2018
Will California’s Cannabis Regulation Limit Commercial Activity Between Licensed and Unlicensed Entities? Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
17
2018
FSIS Announces Move from Pulsed-Field Gel Electrophoresis to Whole Genome Sequencing for Analyzing Shiga Toxin-Producing E. coli (STEC) and Salmonella Isolates Keller and Heckman LLP
Dec
16
2018
EPA Regulatory Environmental Law News Update November 2018 Bergeson & Campbell, P.C.
Dec
14
2018
McDermottPlus Check-Up: December 14, 2018 McDermott Will & Emery
Dec
14
2018
FDA Releases Medical Device De Novo Pathway Proposed Rule Dinsmore & Shohl LLP
Dec
14
2018
FDA and CDC Identify One Source of E. Coli Contaminated Romaine Keller and Heckman LLP
Dec
13
2018
Some BPCIA Clouds Begin to Clear: FDA Issues Final Plans for March 2020 “Deemed to Be a License” Provision Mintz
Dec
13
2018
Contrary to Popular Reports, Farm Bill Will Not Affect FDA Status of CBD Keller and Heckman LLP
Dec
12
2018
Top International News in Chemical Policy and Regulation: December 12, 2018: European Union Bergeson & Campbell, P.C.
Dec
12
2018
FDA Issues Real-World Evidence Framework for Drugs and Biologics McDermott Will & Emery
Dec
12
2018
Second Circuit Remands “Whole Grain” Cheez-It Lawsuit Keller and Heckman LLP
Dec
11
2018
THE LATEST: FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process McDermott Will & Emery
Dec
11
2018
FDA to Overhaul Medical Device Approval Process Epstein Becker & Green, P.C.
Dec
11
2018
Mixed Reactions to Final Rule on School Meal Flexibilities Keller and Heckman LLP
Dec
10
2018
OIG Dusts off the Old Rule Book to Say No to Free Expensive Drugs to Hospitals McDermott Will & Emery
Dec
10
2018
Regulatory Reminder: Updating your U.S. Establishment Registration and Product Listing By December 31, 2018 Keller and Heckman LLP
Dec
10
2018
With Wide-Spread Legalization of Marijuana, Has A Public Employer's Ability to Test for Marijuana Gone up In Smoke? von Briesen & Roper, s.c.
Dec
10
2018
U.S. Department of Justice Sides with California Against States Opposing Egg Production Standards That Require Room for Chickens to Move Keller and Heckman LLP
Dec
7
2018
New Ruling on Medical Marijuana in the Workplace Clarifies Connecticut’s PUMA Legislation Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
7
2018
New York’s Medical Marijuana Program Sees Huge Two-Year Gains Wilson Elser Moskowitz Edelman & Dicker LLP
Dec
7
2018
USDA Issues Final Rule Setting a Uniform Compliance Date for Food Labeling Regulations Keller and Heckman LLP
Dec
6
2018
FDA Reexamining Communication Practices with Investigational New Drug Sponsors Epstein Becker & Green, P.C.
Dec
6
2018
Significant FDA Digital Health Policy Development for Prescription Drug Sponsors Covington & Burling LLP
Dec
6
2018
CMS Proposes Changes to Lower Drug Prices Foley & Lardner LLP
Dec
5
2018
Michigan Employer Action Steps for Recreational Marijuana Barnes & Thornburg LLP
Dec
5
2018
FDA Alerts Consumers to Dog Food Recalls For Potentially Toxic Vitamin D Exposure Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins